EAU 2013 - Programme Book - YouMed

Saturday, 16 March - EAU Programme
Abstract Session
14.15 - 15.45 Bladder cancer: Gene expression and molecular classification
Red Hall 1 - Level N1
Poster Session 13
Chairs: P.J. Boström, Turku (FI)
M. Sanchez-Carbayo, Madrid (ES)
Poster viewing of 20 minutes. Presentations will take place on stage. Standard presentations are 2 minutes
in length, followed by 2 minutes for discussion.
144 Bortezomib synergizes with vorinostat to cause ubiquitinated protein accumulation and histone acetylation
in bladder cancer cells
A. Sato, T. Asano, K. Ito, T. Asano (Tokorozawa, Japan)
145 Whole transcriptome sequencing reveals dynamic changes in gene expression of progressive, lethal
bladder cancer
N. Sapre, G. Macintyre, J. Pedersen, A. Ryan, A. Kowalczyk, P. Anderson, A.J. Costello, N.M. Corcoran,
C.M. Hovens (Melbourne, Australia)
146 Cell membrane glycosphingolipids are involved in the control of bladder cancer invasive properties
A. Bettiga, M. Aureli, G. Colciago, D. Canals, M. Moschini, P. Hedlund, S. Sonnino, Y.A. Hannon, F. Benigni
(Milan, Italy; Charleston, South Carolina, United States of America)
147 In vitro cell viability and proliferation of electrospun scaffold made of PCL and PHBV for tissue engineered
urinary diversions
A. Vianello, A. Giannantoni, V. Maulà, C. Del Gaudio, A. Bianco, G. Bellezza, M. Porena (Perugia, Rome,
Italy)
148 B-cell translocation gene 2: A tumor suppressor gene is upregulated by resveratrol in bladder carcinoma
cells
H-H. Juang, P-L. Chang, K-H. Tsui (Kwei-Shan, Tao-Yuan, Taiwan)
149 CIP2A is associated with human bladder cancer aggressivity
Y. Xue, X. Zou, B. Jiang, G. Zhang, Y. Liao, G. Wu, X. Wang, F. Liu, J. Yang, H. Xu, M. Liu (Ganzhou, China)
150 High expression of HuR in cytoplasm, but not nuclei, associated with malignant aggressiveness and
prognosis in non-muscle invasive bladder cancer
Y. Miyata, K. Ohba, T. Matsuo, K. Mitsunari, Y. Sagara, H. Sakai (Nagasaki, Japan)
151 Association of the expression of T-cell coregulatory proteins with clinical outcomes in patients with
urothelial carcinoma of the bladder
E.N. Xylinas, B.D. Robinson, L.A. Kluth, G. Volkmer, R. Hautmann, R. Kufer, M. Zerbib, E. Kwon,
H. Thompson, S.A. Boorjian, S.F. Shariat (New York, Rochester, United States of America; Kassel, Ulm,
Göppingen, Germany; Paris, France)
152 Targeting DNA repair mechanisms increases efficiency of intravesical chemotherapy in an orthotopic rat
bladder cancer model
C.J. Arum, O.A. Gederaas, S. Bachke, T. Viset, M. Otterlei (Trondheim, Norway)
153 The effect of photochemical internalization of bleomycin in the treatment of urothelial carcinoma of the
bladder: An in vitro study
H.C. Arentsen, J. Falke, A. Høgset, E. Oosterwijk, J.A. Witjes (Nijmegen, The Netherlands; Oslo, Norway)
EAU Milan 2013
121
Saturday